Skip to content

A clinica trial on VISHNUKIRANTI KUDINEER in the management of CEGANAVADHAM (CERVICAL SPONDYLOSIS)

A prospective open labelled non Randomized phaseII clinical trial on VISHNUKIRANTI KUDINEER in the management of CEGANAVADHAM(CERVICAL SPONDYLOSIS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040374
Enrollment
40
Registered
2022-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis Health Condition 2: M478- Other spondylosis

Interventions

Intervention1: Vishnukiranthi kudineer: 30 to 60ml/twice a day (orally) 45 days Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neck pain radiating to upper limb with or without numbness, guiddiness and neck stiffness Restriction neck movememts Willing for doing laboratory investigation and xray imaging The neck diability index score should be equal or greater than 40%

Exclusion criteria

Exclusion criteria: Age less than 20 greater than 60 Traumatic injury Systemic hyper tension Ischeamic heart diseases Chronic kidney disease Tuberculosis of spine Secondary maliganancy Chronic systemic illness Congenital spinal anomaly Pregnancy Lactating mother Extra cervical rib.

Design outcomes

Primary

MeasureTime frame
1.Reduction of the symptoms of painin neck and upper limbs Improvement of the range of movements in the neck and upper limbs The outcome is aimed at reducing pain and increasing the range of movements Good improvement-score 10%/below10% Moderate improvement-score10-20% Mild improvement-score 20-30% No improvement-score 40%Timepoint: 45 days

Secondary

MeasureTime frame
To evaluate the physicochemocal, phytochemicals, biochemical analysis of clinical trial drug To evaluate the safety profile for acute and subacute toxicity of the trial drug To evaluate Antimicrobial activity of the trial drug To evaluate the pharmacological analysis of the clinical trial drug To evaluate siddha parameters and compare the(including envagaithervu) changes in Ceganavadham during trial period To evaluate modern parametric changes in Ceganavadham To evaluate the efficacy of Vishnukiranti kudineer on ceganavadham by the bio statistical analysis.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr A Manoharan MD s Ph D

Govt. Siddha medical college and hospital, Palayamkottai

komalaarumugam1@gmail.com9788122691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026